<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01439984</url>
  </required_header>
  <id_info>
    <org_study_id>CTC-PE-01</org_study_id>
    <nct_id>NCT01439984</nct_id>
  </id_info>
  <brief_title>Trial of PED-1 in Male Patients With Premature Ejaculation</brief_title>
  <official_title>A Randomized, Double-blind, Placebo-controlled, Fixed Dose, Parallel Grouped, Multi-center Clinical Study to Evaluate the Safety and Efficacy of PED-1 in Male Patients With Premature Ejaculation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Symyoo</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Symyoo</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate whether PED-1 is more effective than Placebo in the
      treatment of premature ejaculation.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study is to evaluate whether PED-1 is effective than Placebo in the treatment of
      premature ejaculation. The patients will be randomized and allocated to two treatment groups
      into placebo, PED-1. The criteria for Intravaginal Ejaculation Latency Time(IELT) for
      enrollment will be &gt; or =2 min in the at least 75% of the sexual intercourse. To diagnosis
      premature ejaculation, the PEDT(Premature Ejaculation Diagnosis Tool) will be used. The
      patients undergone drug free baseline period will take test drugs for 12 weeks.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2011</start_date>
  <completion_date type="Actual">June 2012</completion_date>
  <primary_completion_date type="Actual">June 2012</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Intravaginal ejaculation latency time (IELT)(seconds)</measure>
    <time_frame>12 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Drug coitus interval time (hours)</measure>
    <time_frame>12 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">159</enrollment>
  <condition>Premature Ejaculation</condition>
  <arm_group>
    <arm_group_label>PED-1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>PED-1 (Clomipramine 15 mg)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Clomipramine</intervention_name>
    <description>Clomipramine 15 mg tablet or placebo tablet on demand for 12 weeks</description>
    <arm_group_label>PED-1</arm_group_label>
    <arm_group_label>placebo</arm_group_label>
    <other_name>PED-1</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Informed consent for subjects and partners

          -  Men 20-65 ages

          -  Stable monogamous relation at least for 6 mo

          -  Premature Ejaculation Diagnosis Tool (PEDT) more than 9

          -  At least 6 mo of premature ejaculation Hx

          -  IELT of =&lt; 2 min in &gt;= 75% of evaluable events during 4 week screening period

        Exclusion Criteria:

          -  History of medical or psychiatric illness

          -  Erectile dysfunction (&lt;21 International Index of Erectile Function-Erectile Function
             (IIEF-EF) domain score) or other forms of sexual dysfunction

          -  Partner sexual dysfunction

          -  Known hypersensitivity to clomipramine and contraindications for clomipramine
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Whan-Seok Choi, MD,PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Seoul St. Marry's Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Inje University Ilsan Paik Hospital</name>
      <address>
        <city>Goyang-si</city>
        <state>Gyeonggi-do</state>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>National Health Insurance Corporation Ilsan Hospital</name>
      <address>
        <city>Goyang-si</city>
        <state>Gyeonggi-do</state>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Uijeongbu St.Marry's Hospital</name>
      <address>
        <city>Uijeongbu-si</city>
        <state>Gyeonggi-do</state>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ewha Womans University Mokdong Hospital</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Seoul St.Marry's Hospital</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>October 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 18, 2011</study_first_submitted>
  <study_first_submitted_qc>September 22, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 23, 2011</study_first_posted>
  <last_update_submitted>October 1, 2012</last_update_submitted>
  <last_update_submitted_qc>October 1, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 3, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>PE</keyword>
  <keyword>IELT</keyword>
  <keyword>DCIT</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Premature Birth</mesh_term>
    <mesh_term>Premature Ejaculation</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Clomipramine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

